Showing results (91-100 of 10,697) with videos related to
Sort By:
Pageof 1,070
Drugs|January 1, 1986
The role of vasodilator therapy in the treatment of severe chronic heart failureM PackerDiabetes, Obesity & Metabolism|January 10, 2018
Have we really demonstrated the cardiovascular safety of anti-hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetesMilton PackerEuropean Journal of Heart Failure|March 23, 2018
Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medicationsMilton PackerEuropean Journal of Heart Failure|December 19, 2018
The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal rangeMilton PackerInternational Journal of Cardiology|March 18, 2018
Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparatorsMilton PackerCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1987
Resident training in chronic care and rehabilitationS PackerCardiovascular Drugs and Therapy|January 1, 1989
Does digitalis work in chronic heart failure? The end of a 200-year-old controversyM PackerJournal of Cardiovascular Pharmacology|January 1, 1987
Converting-enzyme inhibition in the management of severe chronic congestive heart failure: physiologic conceptsM PackerJournal of the American Heart Association|August 14, 2020
Molecular, Cellular, and Clinical Evidence That Sodium-Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart FailureMilton PackerJournal of the American Society of Nephrology : JASN|June 21, 2023
Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKDMilton PackerPageof 1,070